Tumor ID | Diagnosis | Alive/Dead4 | Survival Time (year)5 | GFAP | FABP7 | Id4 |
---|---|---|---|---|---|---|
2650 | ODG III1 | A | 9.12 | - (MG+)6 | - (MG+) | - (MG+) |
2963 | ODG III | A | 7.28 | - (MG+) | - (MG+) | - (MG+) |
3081 | ODG III | A | 6.97 | - (MG+) | - (MG+) | - (MG+) |
3474* | ODG III | A | 5.67 | + (?)7 | - | - |
3492 | ODG III | D | 5.29 | - | - | - |
3551* | ODG III | A | 5.42 | NI8 | - | - |
3607 | ODG III | D | 3.91 | - | - | - |
3651* | ODG III | A | 5.09 | - | - | - |
3767 | ODG III | A | 4.73 | - | - | - |
3768 | ODG III | A | 4.73 | - | - | - |
3815 | ODG III | A | 4.59 | - (MG+) | -/+9 (MG-) | - (MG-) |
4115 | ODG III | A | 3.64 | - (MG+) | - (MG+) | - (MG+) |
4142 | ODG III | A | 3.55 | - (MG+) | - (MG-) | - (MG-) |
4167 | ODG III | A | 3.48 | -/+ | -/+ | - |
4253 | ODG III | A | 3.26 | - | - | - |
2450 | OAC III2 | A | 9.9 | + | + (cyto/nuc)10 | + (cyto) |
2459 | OAC III | A | 9.9 | + | + (cyto/nuc) | + (cyto) |
2533* | OAC III | A | 6.55 | + | + (cyto) | - |
2609* | OAC III | A | 9.27 | + | + (cyto/nuc) | - |
2622* | OAC III | D | 5.75 | + | - | - |
2668 | OAC III | D | 8.97 | + | + (cyto/nuc) | + (cyto) |
3304 | OAC III | A | 6.27 | + | + (cyto) | + (cyto) |
3378 | OAC III | A | 5.97 | + | + (cyto/nuc) | + (cyto/nuc) |
3729 | OAC II3 | A | 4.85 | + | + (cyto) | - |
4141 | OAC III | A | 3.55 | + | - | - |